News/ News/ News/ Oncology/ Sales and Marketing

Novartis bags FDA okay for BRAF-positive tumour combination

, , , , , , 0 Comment

Novartis’ two-drug regimen of Tafinlar and Mekinist has been approved by the FDA as the first therapy for